RFG Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History

RFG Advisory’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,925	Closed	-$315K	–	47
2014 Q4	$315K	Buy	+1,925	New	+$320K	0.37%	14

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RFG Advisory's JAZZ Position: Q1 2015 in Review

RFG Advisory sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2015, closing a stake of 1,925 shares — an estimated $315K sold.

RFG Advisory first reported a position in JAZZ in Q4 2014 and held it in 1 quarter. The position peaked at $315K in Q4 2014. 354 funds tracked by Wall St. Rank hold JAZZ as of Q1 2015.

RFG Advisory reported no remaining Jazz Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
RFG Advisory sold 1,925 Jazz Pharmaceuticals shares in Q1 2015, an estimated $315K.
RFG Advisory first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 1 quarter.
RFG Advisory's Jazz Pharmaceuticals position peaked at $315K in Q4 2014.
354 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2015.

Based on RFG Advisory's 13F filing for Q1 2015, filed 13 May 2015.